Search Within

Craig Moskowitz

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (6)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (23)
  2. Department of Medicine (23)
  3. GSK Faculty (23)
  4. Hematologic Malignancies, Division of (23)
  5. Human Oncology and Pathogenesis Program (23)
  6. Lymphoma (23)

More Groups

People
  1. Andrew Zelenetz (19)
  2. Matthew Matasar (16)
  3. Anas Younes (15)
  4. Maria Palomba (15)
  5. Andrew Intlekofer (14)
  6. Ahmet Dogan (13)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (2)
  5. 2017 (6)
  6. 2016 (2)

More Years

Publications
  1. Blood (11)
  2. Hematological Oncology (2)
  3. Journal of Clinical Oncology (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. American Society of Clinical Oncology (2)
  3. Nature Publishing Group (2)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)
  6. Elsevier Inc. (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Journal Article

    Vardhana, S. A.; Sauter, C. S.; Matasar, M. J.; Zelenetz, A. D.; Galasso, N.; Woo, K. M.; Zhang, Z.; Moskowitz, C. H.
    British Journal of Haematology (2017)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Meeting Abstract

    Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
    Blood (2015)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Lymphomas
    Book Section

    Word, Z. H.; Moskowitz, C.; Intlekofer, A. M.; Zelenetz, A. D.; Noy, A.; Horwitz, S. M.; Kumar, A.; Kaley, T. J.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save